Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy in mutant-IDH2 (mIDH2) newly diagnosed acute myeloid leukemia (ND-AML).

Courtney Denton Dinardo; Andre C. Schuh; Eytan M. Stein; Pau Montesinos; Andrew Wei; Stephane De Botton; Amer Methqal Zeidan; Amir Tahmasb Fathi; Lynn Quek; Hagop M. Kantarjian; Mark G. Frattini; Frederik Lersch; Jing Gong; Aleksandra Franovic; Paresh Vyas; Hartmut Dohner

Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy in mutant-IDH2 (mIDH2) newly diagnosed acute myeloid leukemia (ND-AML).

Courtney Denton Dinardo, Andre C. Schuh, Eytan M. Stein, Pau Montesinos, Andrew Wei, Stephane De Botton, Amer Methqal Zeidan, Amir Tahmasb Fathi, Lynn Quek, Hagop M. Kantarjian, Mark G. Frattini, Frederik Lersch, Jing Gong, Aleksandra Franovic, Paresh Vyas, Hartmut Dohner

Comprehensive Cancer Centre

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	Journal of Clinical Oncology
Volume	38
Issue number	15
Publication status	Published - 20 May 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Dinardo, C. D., Schuh, A. C., Stein, E. M., Montesinos, P., Wei, A., De Botton, S., Zeidan, A. M., Fathi, A. T., Quek, L., Kantarjian, H. M., Frattini, M. G., Lersch, F., Gong, J., Franovic, A., Vyas, P., & Dohner, H. (2020). Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy in mutant-IDH2 (mIDH2) newly diagnosed acute myeloid leukemia (ND-AML). Journal of Clinical Oncology, 38(15).

@article{a4720bb38477410883483d4d05bd2b0e,

title = "Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy in mutant-IDH2 (mIDH2) newly diagnosed acute myeloid leukemia (ND-AML).",

author = "Dinardo, {Courtney Denton} and Schuh, {Andre C.} and Stein, {Eytan M.} and Pau Montesinos and Andrew Wei and {De Botton}, Stephane and Zeidan, {Amer Methqal} and Fathi, {Amir Tahmasb} and Lynn Quek and Kantarjian, {Hagop M.} and Frattini, {Mark G.} and Frederik Lersch and Jing Gong and Aleksandra Franovic and Paresh Vyas and Hartmut Dohner",

year = "2020",

month = may,

day = "20",

language = "English",

volume = "38",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

}

Dinardo, CD, Schuh, AC, Stein, EM, Montesinos, P, Wei, A, De Botton, S, Zeidan, AM, Fathi, AT, Quek, L, Kantarjian, HM, Frattini, MG, Lersch, F, Gong, J, Franovic, A, Vyas, P & Dohner, H 2020, 'Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy in mutant-IDH2 (mIDH2) newly diagnosed acute myeloid leukemia (ND-AML).', Journal of Clinical Oncology, vol. 38, no. 15.

Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy in mutant-IDH2 (mIDH2) newly diagnosed acute myeloid leukemia (ND-AML). / Dinardo, Courtney Denton; Schuh, Andre C.; Stein, Eytan M. et al.
In: Journal of Clinical Oncology, Vol. 38, No. 15, 20.05.2020.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy in mutant-IDH2 (mIDH2) newly diagnosed acute myeloid leukemia (ND-AML).

AU - Dinardo, Courtney Denton

AU - Schuh, Andre C.

AU - Stein, Eytan M.

AU - Montesinos, Pau

AU - Wei, Andrew

AU - De Botton, Stephane

AU - Zeidan, Amer Methqal

AU - Fathi, Amir Tahmasb

AU - Quek, Lynn

AU - Kantarjian, Hagop M.

AU - Frattini, Mark G.

AU - Lersch, Frederik

AU - Gong, Jing

AU - Franovic, Aleksandra

AU - Vyas, Paresh

AU - Dohner, Hartmut

PY - 2020/5/20

Y1 - 2020/5/20

M3 - Meeting Abstract

SN - 0732-183X

VL - 38

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

ER -